Levophenacylmorphan

Levophenacylmorphan

Clinical data
Other names	Levophenacylmorphan
ATC code	none
Legal status
Legal status	BR: Class A1 (Narcotic drugs) CA: Schedule I DE: Anlage I (Authorized scientific use only) US: Schedule I
Identifiers
IUPAC name (−)-3-Hydroxy-N-phenacylmorphinan
CAS Number	10061-32-2 Y
PubChem CID	5362482
ChemSpider	16736786 N
UNII	7Q24AL2BR2
KEGG	D12687 Y
CompTox Dashboard (EPA)	DTXSID90881401
ECHA InfoCard	100.030.168
Chemical and physical data
Formula	C24H27NO2
Molar mass	361.485 g·mol−1
3D model (JSmol)	Interactive image
SMILES C1CC[C@@]23CCN([C@@H]([C@@H]2C1)CC4=C3C=C(C=C4)O)CC(=O)C5=CC=CC=C5
InChI InChI=1S/C24H27NO2/c26-19-10-9-18-14-22-20-8-4-5-11-24(20,21(18)15-19)12-13-25(22)16-23(27)17-6-2-1-3-7-17/h1-3,6-7,9-10,15,20,22,26H,4-5,8,11-14,16H2/t20-,22+,24+/m0/s1 N Key:RCYBMSQOSGJZLO-BGWNEDDSSA-N N
NY (what is this?)  (verify)

Levophenacylmorphan is a morphinan derivative that acts as an opioid agonist. It has potent analgesic effects and is around 10x more potent than morphine. Adverse effects associated with its use are those of the opioids as a whole, including pruritus, nausea, respiratory depression, euphoria and development of tolerance and dependence to its effects.

See also

• 3-Hydroxymorphinan
• Levorphanol
• Norlevorphanol
• Phenomorphan